Antiretrovirus drugs impair kidneys in HIV-infection
- 作者: Yushchuk N.1, Volgina G.1, Tomilina N.1, Gadzhikulieva M.1, Yuschuk N2, Volgina G3, Tomilina N3, Gadzhikulieva M2
-
隶属关系:
- ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
- Chair of infectious diseases and epidemiology of Moscow State Medicostomatological University, Moscow
- Chair of Nephrology of the postgraduate faculty of Moscow State Medicostomatological University, Moscow
- 期: 卷 83, 编号 11 (2011)
- 页面: 66-70
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30959
- ID: 30959
如何引用文章
全文:
详细
作者简介
Nikolay Yushchuk
ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
Email: shishkina.75@mail.ru
Кафедра инфекционных болезней и эпидемиологии- д-р мед. наук, проф., акад. РАМН, зав. каф. инфекционных болезней и эпидемиологии МГМСУ, тел.: 8-495-631-25-44; ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
Galina Volgina
ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвитиякафедра нефрологии ФПДО- д-р мед. наук, проф., каф. нефрологии ФПДО МГМСУ, тел.: 8-495-631-25-44; ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
Nataliya Tomilina
ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвитиякафедра нефрологии ФПДО- д-р мед. наук, зав. каф. нефрологии ФПДО МГМСУ, тел.: 8-495-631-25-44; ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
Madina Gadzhikulieva
ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
Email: Madina67@mail.ru
Кафедра инфекционных болезней и эпидемиологии- канд. мед. наук, каф. инфекционных болезней и эпидемиологии МГМСУ, тел.: 8-495-365-24-85; ГОУ ВПО Московский государственный медико-стоматологический университет Минздравсоцразвития
N Yuschuk
Chair of infectious diseases and epidemiology of Moscow State Medicostomatological University, MoscowChair of infectious diseases and epidemiology of Moscow State Medicostomatological University, Moscow
G Volgina
Chair of Nephrology of the postgraduate faculty of Moscow State Medicostomatological University, MoscowChair of Nephrology of the postgraduate faculty of Moscow State Medicostomatological University, Moscow
N Tomilina
Chair of Nephrology of the postgraduate faculty of Moscow State Medicostomatological University, MoscowChair of Nephrology of the postgraduate faculty of Moscow State Medicostomatological University, Moscow
M Gadzhikulieva
Chair of infectious diseases and epidemiology of Moscow State Medicostomatological University, MoscowChair of infectious diseases and epidemiology of Moscow State Medicostomatological University, Moscow
参考
- Hammer S. M., Eron Jr. J. J., Reiss P. et al. Recommendations of the International AIDS Society-USA Panel, 2008. J. A. M. A. 2008; 300 (5): 555-570.
- Бартлетт Д., Галлант Д., Фам П. Клинические аспекты ВИЧ-инфекции. 2009-2010. М.: Р. Валент; 2010.
- Jeffrey S., Kasbekar N. Highly active antiretroviral therapy and the kidney: An update on antiretroviral medications for nephrologists. Clin. J. Am. Soc. Nephrol. 2006; 1: 117-129.
- Jao J., Wyatt C. Antiretroviral medications: adverse effects on the kidney. Adv. Chron. Kidney Dis. 2010; 17 (1): 72-82.
- Harris M. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Expert Opin. Drug Saf. 2008; 7: 389-400.
- Белякова Н. А., Рахманова А. Г. Вирус иммунодефицита человека-медицина. СПб.: Балтийский образовательный центр; 2010.
- Izzedine H., Harris M., Perazella M. et al. The nephrotoxic effects of HAART. Nature Rev. Nephrol. 2009; 5: 563-573.
- Dasgupta A., Okhuysen P. С. Pharmacokinetic and other drug interactions in patients with AIDS. Ther. Drug Monit. 2001; 23: 591-605.
- Zager R. A. Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin. Nephrol. 1997; 17: 3-14.
- Ciarimboli G., Individual P. K. Cphosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. J. Am. Soc. Nephrol. 2005; 16: 1562- 1570.
- Rho M., Perazella M. A. Nephrotoxicity associated with antiretroviral therapy in HIV infected patients. Curr. Drug Saf. 2007; 2: 147-154.
- Schetz M., Dasta J., Goldstein S., Golper T. Drug-induced acute renal failure. Curr. Opin. Crit. Care 2005; 11 (6): 555- 565.
- Wyatt С. М., Arons R. R., Klotman P. E. et al. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 20 (4): 561-565.
- Wyatt C., Klotman P. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006; 5 (2): 275-287.
- Fine D., Perazella M., Lucas G. et al. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 2008; 68 (7): 963-980.
- Roe J., Campbell L. J., Ibrahim F. et al. HIV care and the incidence of acute renal failure. Clin. Infect. Dis. 2008; 47: 242-249.
- Reiter W. J., Schon-Pernerstorfer H., Dorfinger K. et al. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed. J. Urol. (Baltimore). 1999; 161: 1082-1084.
- Gallant J. E., Staszewski S., Pozniak A. et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. J. A. M. A. 2004; 292 (2): 191-201.
- Jaradaе M., Phillips C., Yum M. N. et al. Acute tubulointerstitial nephritis attributable to indinavir therapy. Am. J. Kidney Dis. 2000; 35: 16.
- Sarcletti M., Petter A., Romani N. et al. Pyuria in patients treated with indinavir is associated with renal dysfunction. Clin. Nephrol. 2000; 54: 261-270.
- Chan-Tack K. M., Truffa M. M., Struble K. A. et al. Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS 2007; 21 (9): 1215-1218.
- Krishnan M., Nair R., Haas M. et al. Acute renal failure in an HIV-positive50-year-old man. Am. J. Kidney Dis. 2000; 36: 1075-1078.
- Brewster U. С., Perazella M. A. Acute interstitial nephritis associated with atazanavir, a new protease inhibitor. Am. J. Kidney Dis. 2004; 44: 81-84.
- Angel-Moreno-Maroto A., Suarez-Castellano L., Hernandez-Cabrera M. et al. Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure. J. Infect. 2006; 52: 39-40.
- Knudtson E., Para M., Boswell H. et al. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. Obstetr. and Gynecol. 2003; 101: 1094-1097.
- Joshi M. K., Liu H. H. Acute rhabdomyolysis and renal failure in HIV-infected patients: risk factors, presentation, and pathophysiology. AIDS Patient Care STDs 2000; 14: 541-548.
- Castro J. G., Gutierrez L. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. Am. J. Med. 2002; 112: 505.
- Verhelst D., Monge M., Meynard J. L. et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am. J. Kidney Dis. 2002; 40 (6): 1331-1333.
- Lyseng-Williamson K. A., Reynolds N. A., Plosker G. L. Tenofovir disoproxil fumarate: A review of its use in the management of HIV infection. Drugs 2005; 65: 413-432.
- Morris A. A., Baudouin S. V., Snow M. H. Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reversetranscriptase inhibitors. AIDS 2001; 15: 140-141.
- Ahmad M. Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficieniysyndrome. J. Postgrad. 2006; 52: 296-297.
- Seguro A. C. Effects of hypokaliemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats. Clin.Nephrol. 2003; 59: 267-272.
- Kopp J. B., Miller K. D., Mican J. A. el al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann. Intern. Med. 1997; 127: 119-125.
- Gagnon R. F., Tecimer S. N., Watters A. K. el al. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am. J. Kidney Dis. 2000; 36: 507-515.
- Hortin G. L., King C., Miller K. D. et al. Detection of indinavir crystals in urine: dependence on method of analysis. Arch. Pathol. Lab. Med. 2000; 124: 246-250.
- Sarcletti M., Fetter A., Romani N. et al. Pyuria in patients treated with indinavir is associated with renal dysfunction. Clin. Nephrol. 2000; 54: 261-270.
- Nadler R. B., Rubenstein J. N., Eggener S. E. et al. The etiology of urolithiasis in HIV infected patients (Baltimore). J. Urol. 2003; 169: 475-477.
- Koster J. C., Remedi M. S., Qiu H. et al. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 2003; 52: 1695-1700.
- Brown Т. Т. et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch. Intern. Med. 2005; 165: 1179-1180.
- Chow D. C., Souza S. A., Chen R. et al. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin. Trials 2003; 4: 411-416.
- Friis-Moller N., Weber R., Reiss P. et al. Cardiovascular disease risk factors in HIV patients-Association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193.
- Seaberg E. C., Munoz A., Lu M. et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960.
- Crane H. M., Van Rompaey S. E., Kitahata M. M. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 2006; 20: 1019-1026.
- Couzigou C., Daudon M., Meynard J. L. et al. Urolithiasis in HIV-positive patients treated with atazanavir. Clin. Infect. Dis. 2007; 45 (8): 105-108.
- Valencia M. E., Moreno V. Atazanavir-induced nephrolithiasis. Enferm. Infecc. Microbiol. Clin. 2009; 27 (2): 134-135.
- Peraldi M. N., Maslo C., Akposso K. et al. Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol. Dial. Transplant. 1999; 14: 1578-1585.
- Estrella M. M., Parekh R. S., Abraham A. J. et al. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. Acquir. Immune Defic. Syndr. 2010; 55 (2): 217-220.
- Labarga P., Barreiro P., Martin-Carbonero L. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009; 23 (6): 689-696.
- European AIDS Clinical Society (EACS) Guidelines. Version 5. Clinical management and treatment of infected adults in Europe. 2009.
- Gupta S. K., Eustace J. A., Winston J. A. et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the infectious Diseases Society of America. Clin. Infect. Dis. 2005; 40 (11): 1559-1585.